Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
INCY · against 91 other Healthcare companies of similar size
Ranked #10 of 92 · scores higher than 90% of peers
Bars: peers in each 10-point band of the valuation score6 peers with a valuation score of 80–89, including INCY · Click a bar to see the companies
Mainly thanks to its free cash flow yield, earnings yield and EBITDA yield, which are stronger than most Healthcare peers.
| Metric | INCY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 90 reported | 6.7% | 3.1% | 93% | 30% | |
| EBITDA yieldHigher is better · 92 reported | 10.0% | 5.4% | 91% | 50% | |
| Free cash flow yieldHigher is better · 57 reported | 7.9% | 3.8% | 93% | 20% | |
| Book yieldHigher is better · 87 reported | 26.8% | 21.4% | 58% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.5B USD | 95 | 60 | |
| 2 | 68.0B BRL (≈$12.2B) | 94 | 67 | |
| 3 | 4.61T JPY (≈$31.3B) | 93 | 76 | |
| 4 | 14.4B USD | 92 | 71 | |
| 5 | 2.57T JPY (≈$17.5B) | 88 | 62 | |
| 6 | 6.17T JPY (≈$42.0B) | 86 | 70 | |
| 7 | 12.6B EUR (≈$13.9B) | 85 | 73 | |
| 8 | 45.9B USD | 84 | 61 | |
| 9 | 34.3B USD | 83 | 57 | |
| 10 | 23.8B USD | 82 | 84 | |
| 11 | 1.85T JPY (≈$12.5B) | 79 | 55 | |
| 11 | 11.2B EUR (≈$12.3B) | 79 | 63 | |
| 13 | 3.53T JPY (≈$24.0B) | 78 | 68 | |
| 13 | 69.1B BRL (≈$12.4B) | 78 | 57 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score